OCT Agreement and Crossed Precision Study
|ClinicalTrials.gov Identifier: NCT02050880|
Recruitment Status : Completed
First Posted : January 31, 2014
Last Update Posted : September 29, 2014
|Condition or disease|
|Glaucoma Retinal Disease Corneal Disease|
|Study Type :||Observational|
|Actual Enrollment :||119 participants|
|Official Title:||Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
Eyes without pathology.
Eyes with Glaucoma.
Eyes with Retinal Disease.
Eyes with corneal disease including a kerato-refractive group.
- Retinal thickness [ Time Frame: Approximately four hours ]Time frame is the maximum duration of hospital stay
- Optic Disc Analysis [ Time Frame: Approximately four hours ]Time frame is the maximum duration of hospital stay
- Corneal Thickness [ Time Frame: Approximately four hours ]Time frame is the maximum duration of hospital stay
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02050880
|United States, California|
|WCCT Global Opthalmology Research Center|
|Santa Ana, California, United States, 92705|